Showing results (1-10 of 403) with videos related to
Sort By:
Pageof 41
Expert Review of Endocrinology & Metabolism|October 7, 2018
A comparison of strontium ranelate and PTH(1-84)Kim Henriksen, Claus Christiansen, Morten A KarsdalMolecular Metabolism|November 9, 2020
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseasesNina Sonne, Morten A Karsdal, Kim HenriksenEuropean Journal of Pharmacology|June 17, 2023
Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight lossAnna Thorsø Larsen, Morten A Karsdal, Kim HenriksenPlos One|June 20, 2020
The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional studyDitte S Jonesco, Morten A Karsdal, Kim HenriksenCalcified Tissue International|May 24, 2013
Osteoclast-derived coupling factors in bone remodelingKim Henriksen, Morten A Karsdal, T John MartinCalcified Tissue International|October 30, 2008
Characterization of the bone phenotype in ClC-7-deficient miceAnita Vibsig Neutzsky-Wulff, Morten A Karsdal, Kim HenriksenBest Practice & Research. Clinical Obstetrics & Gynaecology|July 30, 2013
Musculoskeletal ageing and primary preventionAnders Nedergaard, Kim Henriksen, Morten A Karsdal, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2008
Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone qualityMorten A Karsdal, Kim Henriksen, Michel Arnold, et al.Journal of Cachexia, Sarcopenia and Muscle|September 22, 2012
Serological muscle loss biomarkers: an overview of current concepts and future possibilitiesAnders Nedergaard, Morten A Karsdal, Shu Sun, et al.European Journal of Pharmacology|November 22, 2022
Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozinSimone A Melander, Anna Katri, Morten A Karsdal, et al.Pageof 41